Toxicological Sciences delivers cutting-edge research in toxicology in the areas of clinical and translational toxicology, emerging technologies, and more in the August 2021 issue.
Computational biologist Thomas Norman, PhD, of Memorial Sloan Kettering’s (MSK) Sloan Kettering Institute (SKI) has been named one of 53 recipients of the prestigious 2020 National Institutes of Health (NIH) Director’s New Innovator Award. As part of the award, Dr. Norman will receive $1.5 million in direct costs upfront in the first year of a five-year award.
Harvard Medical School has named Robert Gentleman as founding executive director of the newly established Center for Computational Biomedicine.
Gentleman, an accomplished statistician and computational scientist with extensive experience in academia and industry, most recently served as vice president of computational biology at the genetic testing company 23andMe.
At the AVS 66th International Symposium and Exhibition, Oct. 20-25, Daniel Gunlycke will present a study on using symmetry to reduce the effects of random quantum entanglement in quantum computing applications. When deliberate, quantum entanglement can make algorithms more powerful and efficient, but uncontrolled entanglement adds unnecessary additional complexity to quantum computing, making algorithms suboptimal and more prone to error. Gunlycke says by reducing the frequency of accidental entanglements, quantum computing can be improved.